A Study Comparing Diclofenac Sodium Gel 3% to Solaraze® Gel 3% in the Treatment of Actinic Keratosis

Clinical trial NCT01742663 · COMPLETED

Trial details

NCT number: NCT01742663
Sponsor: Sun Pharmaceutical Industries, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Actinic Keratosis

Start date: 2012-10-01
Primary completion: 2013-07-01
Enrollment: 435

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.